Viral Vector and Plasmid DNA Manufacturing Market Revenue 2024 to 2034
Viral Vector and Plasmid DNA Manufacturing Market Revenue 2024 to 2034
The global viral vector and plasmid DNA manufacturing market size was estimated at US$ 6.01 billion in 2023 and is projected to grow to US$ 43.04 billion by 2034, rising at a compound annual growth rate (CAGR) of 20.7% from 2024 to 2034. The evolving usage of plasmids and vectors in various applications is driving the market’s growth.
Report ID: 10174
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 7.26 Bn
Forecast Year,
USD USD 43.04 Bn
CAGR, 2025 -
20.7%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Viral Vector and Plasmid DNA Manufacturing Market Size Analysis
Viral Vector and Plasmid DNA Manufacturing Market Size By Vector Type 2024 to 2034 (USD )
| Vector Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Adeno-associated virus (AAV) | 1815.00 | 2199.47 | 2665.33 | 3229.82 | 3913.81 | 4742.56 | 5746.72 | 6963.39 | 8437.51 | 10223.55 | 12387.47 |
| Adenovirus | 1089.00 | 1311.79 | 1580.16 | 1903.43 | 2292.81 | 2761.85 | 3326.81 | 4007.34 | 4827.04 | 5814.40 | 7003.69 |
| Retrovirus | 726.00 | 874.53 | 1053.44 | 1268.95 | 1528.54 | 1841.23 | 2217.88 | 2671.56 | 3218.03 | 3876.27 | 4669.12 |
| Lentivirus | 1089.00 | 1318.80 | 1597.09 | 1934.06 | 2342.12 | 2836.24 | 3434.56 | 4159.07 | 5036.35 | 6098.61 | 7384.84 |
| Plasmids | 1815.00 | 2199.47 | 2665.33 | 3229.82 | 3913.81 | 4742.56 | 5746.72 | 6963.39 | 8437.51 | 10223.55 | 12387.47 |
| Others | 726.00 | 858.76 | 1015.37 | 1200.01 | 1417.60 | 1673.85 | 1975.44 | 2330.16 | 2747.10 | 3236.80 | 3811.53 |
Viral Vector and Plasmid DNA Manufacturing Market Size By Disease 2024 to 2034 (USD )
| Disease | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cancer | 2904.00 | 3509.51 | 4241.27 | 5125.59 | 6194.29 | 7485.81 | 9046.60 | 10932.79 | 13212.23 | 15966.90 | 19295.87 |
| Genetic Disorders | 1815.00 | 2195.09 | 2654.76 | 3210.68 | 3882.99 | 4696.07 | 5679.38 | 6868.56 | 8306.70 | 10045.92 | 12149.25 |
| Infectious Diseases | 1815.00 | 2186.32 | 2633.60 | 3172.38 | 3821.35 | 4603.08 | 5544.69 | 6678.89 | 8045.07 | 9690.66 | 11672.81 |
| Others | 726.00 | 871.90 | 1047.10 | 1257.46 | 1510.05 | 1813.33 | 2177.47 | 2614.66 | 3139.54 | 3769.69 | 4526.19 |
Viral Vector and Plasmid DNA Manufacturing Market Size By Workflow 2024 to 2034 (USD )
| Workflow | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Downstream Manufacturing | 3993.00 | 4823.93 | 5827.77 | 7040.51 | 8505.60 | 10275.55 | 12413.82 | 14997.03 | 18117.76 | 21887.88 | 26442.49 |
| Upstream Manufacturing | 3267.00 | 3938.89 | 4748.95 | 5725.60 | 6903.09 | 8322.73 | 10034.32 | 12097.87 | 14585.78 | 17585.30 | 21201.63 |
Viral Vector and Plasmid DNA Manufacturing Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vaccinology | 1452.00 | 1756.95 | 2125.92 | 2572.37 | 3112.56 | 3766.15 | 4556.97 | 5513.81 | 6671.52 | 8072.26 | 9767.04 |
| Cell Therapy | 1815.00 | 2195.09 | 2654.76 | 3210.68 | 3882.99 | 4696.07 | 5679.38 | 6868.56 | 8306.70 | 10045.92 | 12149.25 |
| Antisense & RNAi Therapy | 1089.00 | 1317.05 | 1592.85 | 1926.41 | 2329.79 | 2817.64 | 3407.63 | 4121.13 | 4984.02 | 6027.55 | 7289.55 |
| Gene Therapy | 2178.00 | 2620.08 | 3151.86 | 3791.53 | 4560.97 | 5486.49 | 6599.75 | 7938.80 | 9549.43 | 11486.69 | 13816.80 |
| Research Applications | 726.00 | 873.65 | 1051.33 | 1265.12 | 1522.38 | 1831.93 | 2204.41 | 2652.59 | 3191.87 | 3840.74 | 4621.48 |
Viral Vector and Plasmid DNA Manufacturing Market Size By End-use 2024 to 2034 (USD )
| End-use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Research Institutes | 2904.00 | 3500.75 | 4220.11 | 5087.29 | 6132.66 | 7392.82 | 8911.91 | 10743.13 | 12950.60 | 15611.64 | 18819.43 |
| Pharmaceutical and Biopharmaceutical Companies | 4356.00 | 5262.07 | 6356.61 | 7678.81 | 9276.03 | 11205.47 | 13536.22 | 16351.77 | 19752.94 | 23861.53 | 28824.69 |
Viral Vector and Plasmid DNA Manufacturing Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2904.00 | 3509.51 | 4241.27 | 5125.59 | 6194.29 | 7485.81 | 9046.60 | 10932.79 | 13212.23 | 15966.90 | 19295.87 |
| Asia Pacific | 1815.00 | 2195.09 | 2654.76 | 3210.68 | 3882.99 | 4696.07 | 5679.38 | 6868.56 | 8306.70 | 10045.92 | 12149.25 |
| Europe | 1452.00 | 1749.94 | 2109.00 | 2541.73 | 3063.25 | 3691.76 | 4449.22 | 5362.08 | 6462.22 | 7788.06 | 9385.89 |
| Latin America | 580.80 | 697.52 | 837.68 | 1005.97 | 1208.04 | 1450.67 | 1741.98 | 2091.73 | 2511.63 | 3015.75 | 3620.95 |
| Middle East and Africa | 508.20 | 610.77 | 734.02 | 882.14 | 1060.12 | 1273.98 | 1530.96 | 1839.74 | 2210.76 | 2656.54 | 3192.16 |
Viral Vector and Plasmid DNA Manufacturing Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
